A comparative study of serum alpha 1-microglobulin and beta 2-microglobulin levels in cancerous and other diseases

Clinica Chimica Acta; International Journal of Clinical Chemistry
K TakagiT Kawai

Abstract

The levels of serum alpha 1-microglobulin in 60 normal persons and in 191 patients suffering from a variety of benign and malignant disorders were determined by an enzyme immunoassay, and these values were compared with the levels of beta 2-microglobulin. A discrepancy between the serum levels of these proteins was found in hepatobiliary disorders; that is, an increased serum level of beta 2-microglobulin was observed in 73.9%, while in only 4.3% was there an elevation of alpha 1-microglobulin. In particular, alpha 1-microglobulin levels in patients with liver cirrhosis were well below the normal range, while beta 2-microglobulin levels were elevated. Elevated levels of both proteins were noted in patients with some impairments of renal function, particularly in chronic renal failure, and in immunological diseases. In 81 patients with neoplastic diseases, a high alpha 1-microglobulin value was found in only 15 patients (16.4%), while a high beta 2-microglobulin value in 62 patients (76.5%). The serum levels of both alpha 1-microglobulin and beta 2-microglobulin were especially high in plasma cell dyscrasia with Bence Jones protein, but other neoplastic diseases were mostly associated with beta 2-microglobulin elevation alone.

References

Mar 15, 1976·Clinica Chimica Acta; International Journal of Clinical Chemistry·J ShusterM D Poulik
Aug 18, 1975·Biochemical and Biophysical Research Communications·B EkströmI Berggård
Feb 1, 1979·The Journal of Clinical Investigation·K TakagiT Shikata
Dec 1, 1976·Clinica Chimica Acta; International Journal of Clinical Chemistry·L Svensson, U Ravnskov
Dec 1, 1971·Scandinavian Journal of Clinical and Laboratory Investigation·P E EvrinI Berggård
Mar 1, 1973·The Journal of Experimental Medicine·T H HütterothM D Poulik
Jan 1, 1973·Nephron·L WibellI Berggård
Jan 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·P A PetersonJ B Lindblom
Jul 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·P A PetersonG M Edelman
Jan 24, 1973·Clinica Chimica Acta; International Journal of Clinical Chemistry·P E Evrin, L Wibell
Aug 1, 1980·Journal of Clinical Pathology·K TakagiT Kawai

❮ Previous
Next ❯

Citations

Feb 28, 1986·Clinica Chimica Acta; International Journal of Clinical Chemistry·O W Bjerrum, H S Birgens
Feb 1, 1992·Australian Dental Journal·W ManzarK R Keshavamurthy
Mar 1, 1983·Journal of Clinical Pathology·H YuI C MacLennan
Nov 1, 1988·Journal of Clinical Pathology·J L Fernández-LunaE Méndez
Apr 1, 1989·Transplant International : Official Journal of the European Society for Organ Transplantation·L BäckmanF Dati
Mar 10, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Alessandra di MasiPaolo Ascenzi
Jan 13, 1999·The Japanese Journal of Thoracic and Cardiovascular Surgery : Official Publication of the Japanese Association for Thoracic Surgery = Nihon Kyōbu Geka Gakkai Zasshi·T NarisawaT Takaba
Jul 1, 1985·Scandinavian Journal of Haematology·O W Bjerrum, T Plesner
Nov 10, 2004·The Biochemical Journal·Jasjit S GrewalSaeed R Khan
Aug 1, 1985·Klinische Wochenschrift·M H WeberF Scheler
Nov 4, 2000·Biochimica Et Biophysica Acta·B AkerströmA Lindqvist
Jun 1, 1990·Trends in Biochemical Sciences·B Akerström, L Lögdberg
Jul 17, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·Joris Penders, Joris R Delanghe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.